Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance

Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes

(2013) Giovanni Sartore et al.   ACTA DIABETOLOGICA

Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus

(2013) Keiichi Torimoto et al.   Cardiovascular Diabetology

Evaluation of the Mean Absolute Glucose Change as a Measure of Glycemic Variability Using Continuous Glucose Monitoring Data

(2013) Klaus-Dieter Kohnert et al.   Diabetes Technology & Therapeutics

Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring

(2013) Jian Zhou et al.   MEDICAL SCIENCE MONITOR

Glucose Response Curve and Type 2 Diabetes Risk in Latino Adolescents

(2012) J. Y. Kim et al.   DIABETES CARE

The Use of a Computer Program to Calculate the Mean Amplitude of Glycemic Excursions

(2011) Gert Fritzsche et al.   Diabetes Technology & Therapeutics

Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups

(2011) Nathan R. Hill et al.   Diabetes Technology & Therapeutics

Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese

(2011) Rie Oka et al.   ENDOCRINE JOURNAL

Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline

(2011) David C. Klonoff et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study

(2010) R. Borg et al.   DIABETOLOGIA

New and Improved Methods to Characterize Glycemic Variability Using Continuous Glucose Monitoring

(2009) David Rodbard   Diabetes Technology & Therapeutics

Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring

(2009) David Rodbard et al.   Diabetes Technology & Therapeutics

 -Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes: Comparison of Surrogate Markers With First-Phase Insulin Secretion From an Intravenous Glucose Tolerance Test

(2008) A. Festa et al.   DIABETES